Intermountain Health presenta nueva evaluación de las necesidades de salud comunitaria de Nevada y estrategias de implementación para mejorar la salud de los residentes
<![CDATA[Intermountain Health Newsroom]]>· Original source
🌍Industryfiercepharma.com
Simulated Advisory Boards for Biopharma Team
Fierce Pharma (Latest)· Original source
🌍Industryfiercebiotech.com
Simulated Advisory Boards for Biopharma Team
Fierce Biotech (Latest)· Original source
🇺🇸Industrycertara.com
Optimize Readiness for MHRA-NICE Aligned Pathway
Certara· Original source
🇺🇸Industryinvestors.abeonatherapeutics.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abeona Therapeutics· Original source
🇺🇸Industrycertara.com
Understanding LC/MS/MS
Certara· Original source
🇯🇵Industrynippon-shinyaku.co.jp
第18回「日本新薬こども文学賞」 最優秀賞作品決定
Nippon Shinyaku News· Original source
🇺🇸Industrythefdalawblog.com
Drug Amount Reporting: FDA Publicly Identifies over 7,700 Noncompliant Companies
Hyman, Phelps & McNamara (FDA Law)· Original source
🌍Industryhealth.ucdavis.edu
Cold hands, warm heart — Researchers solve medical mystery of why TRPM4 mutations affect skin and heart differently
UC Davis Health· Original source
🇯🇵Industrysanten.com
「健康経営優良法人2026（大規模法人部門）」に認定
Santen Pharmaceutical News· Original source
🇯🇵Industrysanten.com
S&P GlobalによるSustainability Yearbook Member 2026に選定
20F - Annual Report of the financial statments as of December 31, 2025
InterCure· Original source
🇯🇵Industrykifu-shinsei.jp
2026年度「参天製薬 奨学寄付プログラム」の応募を開始いたしました
Santen Pharmaceutical News· Original source
🇺🇸Industrycertara.com
IO Simulator: A QSP Platform for Immuno-Oncology
Certara· Original source
🇺🇸Industrybiomarin.com
Monica Mann Reflects on a Life Dedicated to Healthcare Transformation
BioMarin Pharmaceutical· Original source
🇺🇸Industrytechcyte.com
Techcyte announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability
Techcyte· Original source
🌍Industryapple.com
Apple reports second quarter results
Apple Health Newsroom· Original source
🌍Industryfiercebiotech.com
Scaling theranostics through access, safety and trust
Fierce Biotech (Latest)· Original source
🌍Industrynews.intermountainhealth.org
Intermountain Health Unveils New Nevada Community Health Needs Assessment and Implementation Strategy to Enhance Health of Residents
<![CDATA[Intermountain Health Newsroom]]>· Original source
🌍Industryorchestrabiomed.com
Strengthening AVIM Therapy’s Regulatory Pathway: A Second FDA Breakthrough Device Designation
Orchestra BioMed· Original source
🇺🇸Industrycertara.com
Why use Pinnacle 21 Enterprise over Community?
Certara· Original source
🌍Industrynews.intermountainhealth.org
Intermountain Health Fillmore Community Hospital Breaks Ground on Emergency Department Expansion to Enhance Access to Care for Residents
<![CDATA[Intermountain Health Newsroom]]>· Original source
🇺🇸Industrynews.abbvie.com
Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month
AbbVie News· Original source
🇮🇹Industryrecordati.com
Media – RECORDATI: SUMMARY REPORT OF THE VOTES – ORDINARY AND EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS 29.04.2026
Recordati· Original source
🌍Industryaptose.com
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
Aptose Biosciences· Original source
🇺🇸Industrybristolmyers2016ir.q4web.com
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
Bristol-Myers Squibb News· Original source
🇺🇸Industryinvestor.lilly.com
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
Eli Lilly News· Original source
🇺🇸Industrymerck.com
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
Merck & Co. (MSD) News· Original source
🇮🇹Industryrecordati.com
MEDIA – Press release (on “il Sole 24 Ore”) – 2025 final payment dividend
Recordati· Original source
🇺🇸Industrybambusatx.com
Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis
Bambusa Therapeutics· Original source
🌍Industryhealth.ucdavis.edu
Vascular surgery resident receives grant to develop AI model to assess surgical technical skills
UC Davis Health· Original source
🇨🇭Industryroche.com
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
Roche Newsroom· Original source
🇺🇸Industrythefdalawblog.com
FDA-Approved Marijuana Products and Those Subject to State-Issued Licenses Rescheduled; Marijuana Hearing Calendared; Dispensary Applications Accepted
Hyman, Phelps & McNamara (FDA Law)· Original source
🌍Industrywuxibiologics.com
PatroLab™ Digital Platform
WuXi Biologics· Original source
🇯🇵Industryotsuka.co.jp
Otsuka Launches "Educational Materials and Resources by Otsuka" for Educators to Support Health Education in Schools Providing Free Digital Health Education Materials on Heat Illness Prevention and Nutrition Education
Otsuka Pharmaceutical· Original source
🇺🇸Industrycertara.com
How to Draw Stereochemistry in Clear and Accurate Chemical Figures
Certara· Original source
🇺🇸Industrycertara.com
RICT 2026
Certara· Original source
🌍Industryscripps.org
Crushed Thumb Couldn’t Stop Scripps LJ Team From Getting Groom to the Altar
Scripps Health· Original source
🌍Industryscripps.org
Media Cover $75M Gift to Name Rady Tower at Scripps Memorial Hospital La Jolla
Scripps Health· Original source
🌍Industryfiercepharma.com
De-Risk Your Program White paper attached
Fierce Pharma (Latest)· Original source
🇺🇸Industrybiomarin.com
Tommaso Corio Discusses His Journey from BioMarin Internship to International Impact
BioMarin Pharmaceutical· Original source
🇺🇸Industrycertara.com
QSP at an Inflection Point: Scaling Impact
Certara· Original source
🇺🇸Industrybeamtx.com
Breaking new ground to advance science with the potential to change lives | Beam Therapeutics
RECORDATI: THE SHAREHOLDERS’ MEETING APPROVES THE 2025 FINANCIAL STATEMENTS AND THE DIVIDEND OF €1.34 PER SHARE (+5.5% VS. 2024). NEW BOARD OF STATUTORY AUDITORS APPOINTED
From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development
Certara· Original source
🌍Industryeledon.com
We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment
Eledon Pharmaceuticals· Original source
🇧🇷Industryems.com.br
EMS avança na área de medicamentos genéticos e firma parceria com biotech dos EUA
EMS Pharma News· Original source
🌍Industryscripps.org
Ernest and Evelyn Rady Commit $75 Million to Scripps Health
Scripps Health· Original source
🌍Industryorchestrabiomed.com
From Blood Pressure Reduction to Cardiac Function: What New AVIM Therapy Data Signal
Orchestra BioMed· Original source
🇺🇸Industryyprime.com
YPrime AI-Powered eCOA Calculation Engine
YPrime· Original source
🇧🇷Industryems.com.br
EMS na Mídia
EMS Pharma News· Original source
🇧🇷Industryems.com.br
Lista Forbes: As 10 Empresas Mais Inovadoras do Brasil
EMS Pharma News· Original source
🇧🇷Industryems.com.br
EMS faz parceria com a norte-americana Biotech para desenvolver tratamentos de alta complexidade
EMS Pharma News· Original source
🌍Industrybioinformaticsonline.com
Update for LEGE
BioInformatics Online· Original source
🇬🇧Industrygsk.com
Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA
GSK News· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
AbbVie News· Original source
🌍Industrybenitec.com
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Benitec Biopharma· Original source
🌍Industryir.biolinerx.com
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
BioLineRx· Original source
🇺🇸Industrymerck.com
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
Merck & Co. (MSD) News· Original source
🇪🇸Industryrovi.es
Cuidar de las personas, construir prevención
Laboratorios Rovi· Original source
🌍Industryuk-cpi.com
CPI strengthens route to market for novel foods with expanded pilot-scale capability
CPI (Healthcare Innovation)· Original source
🌍Industryhealth.ucdavis.edu
Ralph de Vere White Symposium spotlights young cancer researchers
UC Davis Health· Original source
🇺🇸Industrythefdalawblog.com
Not So Fast: When “RAPID” Isn’t Enough
Hyman, Phelps & McNamara (FDA Law)· Original source
🇯🇵Industrytaiho.co.jp
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Otsuka Holdings RSS· Original source
🇯🇵Industrytaiho.co.jp
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development
Otsuka Holdings RSS· Original source
🌍Industrypetros.com
Shop — Petro's Chili & Chips™
Petros Pharmaceuticals· Original source
🌍Industrypetros.com
Menu — Petro's Chili & Chips™
Petros Pharmaceuticals· Original source
🌍Industrypetros.com
Petro's Chili & Chips™
Petros Pharmaceuticals· Original source
🌍Industrypetros.com
404 Error — Petro's Chili & Chips™
Petros Pharmaceuticals· Original source
🇺🇸Industrycertara.com
Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA
Certara· Original source
🇺🇸Industrycertara.com
ACS Fall 2026
Certara· Original source
🌍Industrynews.intermountainhealth.org
Intermountain Health St. Vincent Regional Hospital in Billings, Montana, Receives Nursing Magnet Recognition
<![CDATA[Intermountain Health Newsroom]]>· Original source
Intermountain Health & Madisonhealth to Host Community Open House in Rexburg, Idaho, on May 5 for New Air Medical Base
<![CDATA[Intermountain Health Newsroom]]>· Original source
🇫🇷Industrycellectis.com
Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting
Cellectis· Original source
🌍Industryadial.com
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
Adial Pharmaceuticals· Original source
🇨🇦Industryinvestor.jazzpharma.com
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Zymeworks· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
AbbVie News· Original source
🇬🇧Industrygsk.com
GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH
GSK News· Original source
🌍Industrycormedix.com
CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE III RESPECT TRIAL ASSESSING REZZAYO® FOR THE PROPHYLAXIS OF INVASIVE FUNGAL DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS
CorMedix· Original source
🌍Industrynervgen.com
NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer
NervGen Pharma· Original source
🇺🇸Industryinvestor.lilly.com
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
Eli Lilly News· Original source
🇬🇧Industrygsk.com
TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation
GSK News· Original source
🌍Industryhealth.ucdavis.edu
Toxic PCBs, sex-biased genes and the developing brain
UC Davis Health· Original source
🌍Industrymonashhealth.org
Building confidence through cricket: Tooradin’s Wellness Through Wickets success
Monash Health· Original source
🇯🇵Industrynewsroom.astellas.com
Financial Results of Astellas for FY2025
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Notice Regarding Impairment Loss and Extraordinary Losses in Non-consolidated Financial Results(J-GAAP)
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Notice of Nominees for Directors
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Astellas Announces Personnel Change
Astellas Pharma· Original source
🇯🇵Industrysumitomo-pharma.com
Notice regarding Withdrawal of Shelf Registration Statement for Issuance of New Shares
Sumitomo Pharma· Original source
🌍Industryzentiva.com
Zentiva appeals EU court decision on Urban Wastewater Directive
Zentiva (Global)· Original source
🌍Industryscripps.org
Hospital Therapy Dogs Celebrated at Annual Lunch
Scripps Health· Original source
🌍Industryscripps.org
Placenta Complications in Pregnancy: What to Know (video/podcast)
Scripps Health· Original source
🇧🇷Industryems.com.br
EMS investiu mais de R$ 1,2 bi em planta de peptídeos em 10 anos
EMS Pharma News· Original source
🌍Industryfiercepharma.com
Accelerating clinical trials with precision logistics
Fierce Pharma (Latest)· Original source
🇯🇵Industrynippon-shinyaku.co.jp
日本新薬アドバンス主催「ふれあいまつり」を開催
Nippon Shinyaku News· Original source
🌍Industrybiospace.com
BioSpace elevates journalism as biopharma evolves in the Trump era
BioSpace Newsroom· Original source
🇺🇸Industrybristolmyers2016ir.q4web.com
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
Bristol-Myers Squibb News· Original source
🇺🇸Industrymerck.com
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
Merck & Co. (MSD) News· Original source
🌍Industrywuxibiologics.com
The Global CRDMO Advantage: How WuXi Biologics Accelerates Complex Formats with Industry-Leading Timelines and Technical Expertise
WuXi Biologics· Original source
🌍Industrywuxibiologics.com
WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
WuXi Biologics· Original source
🇯🇵Industrychugai-pharm.co.jp
2026年12月期第1四半期連結決算
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
Chugai Announces 2026 1st Quarter Results
Chugai Pharmaceutical· Original source
🇯🇵Industrychugai-pharm.co.jp
組織改正・人事のお知らせ
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
Organizational and Personnel Changes
Chugai Pharmaceutical· Original source
🇯🇵Industrychugai-pharm.co.jp
信託型株式報酬制度の導入に伴う株式取得の詳細決定に関するお知らせ
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System
Chugai Pharmaceutical· Original source
🌍Industryhealth.ucdavis.edu
David Amaral receives INSAR Lifetime Achievement Award for autism research
UC Davis Health· Original source
🇯🇵Industrynewsroom.astellas.com
Astellas Amends Settlement and License Agreement with MSN regarding Myrbetriq®
Astellas Pharma· Original source
🇺🇸Industrythefdalawblog.com
Results May Vary, But Reporting Shouldn’t: FDA Sends a Not-So-Gentle Reminder on ClinicalTrials.gov Compliance
Hyman, Phelps & McNamara (FDA Law)· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
AbbVie News· Original source
🌍Industryfiercebiotech.com
Breaking the Compliance Bottleneck: Scaling AI and Innovation in Regulated Industries
Fierce Biotech (Latest)· Original source
🇺🇸Industrycertara.com
Certara Enables Discovery Scientists to Accelerate Therapeutic Peptide Discovery with New D360 version
Certara· Original source
🇺🇸Industryir.codexis.com
Codexis to Report First Quarter 2026 Financial Results on May 7
Codexis· Original source
🇺🇸Industrycertara.com
Top 10 Benefits of Simcyp® Simulator for Drug Development
Certara· Original source
🇧🇪Industrypharma.be
Dierproeven: verminderen, verfijnen, vervangen
pharma.be Belgium· Original source
🌍Industrywuxibiologics.com
Early-Stage Developability Assessment for Modality-Driven Lead Optimization and Selection
WuXi Biologics· Original source
🇧🇪Industrypharma.be
Van cijfers naar keuzes: hoe houden we de innovatiespiraal draaiende?
pharma.be Belgium· Original source
🇧🇪Industrypharma.be
Wereldvaccinatieweek 2026: ouderen willen zich laten vaccineren, maar missen een duidelijk vaccinatiebeleid
pharma.be Belgium· Original source
🌍Industrymonashhealth.org
Changes to pathology results from Sunday, 3 May
Monash Health· Original source
🇨🇭Industryroche.com
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
Roche Newsroom· Original source
🇫🇷Industryipsen.com
Strong Q1 2026 sales growth, marking a solid start to the year
Ipsen RSS· Original source
🇯🇵Industrychugai-pharm.co.jp
エフ・ホフマン・ラ・ロシュの2026年第1四半期の販売実績について
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
F. Hoffmann-La Roche Announces First Quarter Sales 2026
Chugai Pharmaceutical· Original source
🇺🇸Industrycsafeglobal.com
CSafe Advanced Parcel Data Sheet
CSafe Global· Original source
🇺🇸Industrythefdalawblog.com
What Does DOJ’s New Corporate Enforcement Policy Mean for the FDA- and DEA-Regulated Industry?
Hyman, Phelps & McNamara (FDA Law)· Original source
🌍Industrywuxibiologics.com
WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics
WuXi Biologics· Original source
🇯🇵Industryrecormedical.com
Recor Medical's Paradise Ultrasound Renal Denervation System Honored with TAG Award for Cardiovascular Therapeutic Innovation (Link to Recor website)
